Corrigendum: PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors (PPAR Research (2010) 2010 (427401) DOI: 10.1155/2010/427401)

Abstract

The article titled PPARs in Human Neuroepithelial Tumors: PPARLigands asAnticancerTherapies for theMostCommon Human Neuroepithelial Tumors [1] was found to contain material in Sections 1, 2, and 3 from published work and to have missing attributions and errors in citations.The articles are as follows: (i) M. T. Heneka and G. E. Landreth, PPARs in the brain, Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 10311045, 2007. https://doi.org/10.1016%2fj.bbalip .2007.04.016. [2] (Cited as reference [36]). (ii) Lars Tatenhorst, Eric Hahnen, and Michael T. Heneka, Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors, PPAR Research, vol. 2008, Article ID 204514, 9 pages, 2008. https://doi.org/ 10.1155/2008/204514. [3] (not cited). (iii) Markus P. Kummer and Michael T. Heneka, PPARs in Alzheimer's Disease, PPAR Research, vol. 2008, Article ID 403896, 8 pages, 2008. https://doi.org/ 10.1155/2008/403896. [4] (not cited). (iv) J. N. Feige, L. Gelman, L. Michalik, B. Desvergne, and W. Wahli, From molecular action to physiological outputs: peroxisome proliferatoractivated receptors are nuclear receptors at the crossroads of key cellular functions, Progress in Lipid Research, vol. 45, no. 2, pp. 120159, 2006. https://doi.org/10.1016%2fj.plipres.2005.12.002. [5] (cited as reference [30]). (v) A. Cimini, E. Benedetti, L. Cristiano et al., Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons, Neuroscience, vol. 130, no. 2, pp. 325337, 2005. https://doi.org/10.1016%2fj.neuroscience. 2004.09.043. [6] (cited as reference [81]).